IMM-5601

N/A

Report date: 2022/01/19 17:57:14

Base Information

Drug NameIMM-5601

Drug Alias NameIMM-5601

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionCluster of differentiation 47 inhibitors

TargetsCluster of differentiation 47

Therapy Area/IndicationsMultiple Myeloma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd

Inactive CompaniesN/A

Active IndicationsMultiple Myeloma

Inactive IndicationsN/A

Other Information

ATC CodeN/A